In the current study, Levine led a team of scientists from the NIDDK and the National Cancer Institute (NCI), both components of the NIH, as well as the University of Kansas.
The NIDDK says that although people believe that TUIP gives the same relief as TURP with less risk of side effects, its advantages and long-term side effects have not been clearly established.